India Britain covid-19 vaccine strain Coronavirus India Britain

Novavax’s jab 96% effective against original coronavirus strain

Reading now: 125
www.livemint.com

Also Read | Dissecting Ola’s audacious electric dreamsThe announcement is significant for India in its fight against covid-19 pandemic, where the world’s largest vaccine manufacturer, Serum Institute of India, will be manufacturing 1 billion doses of the shot under its brand Covovax.The data was from its UK trials, where it has enrolled more than 15,000 participants, including 27% over the age of 65.The vaccine was 86.3% effective against the mutant variant discovered in the UK.

The overall efficacy across its UK trial was 89.7%, similar to the 89.3% interim efficacy the company had reported in January.In the UK trial, 106 participants were confirmed to have contracted covid-19, with only 10 in the vaccine group and the rest in the placebo.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA